Skip to main content
. 2005 Apr 22;1:2. doi: 10.1186/1744-9081-1-2

Figure 3.

Figure 3

The enhancing effects of methylphenidate were blocked by co-administration of the dopamine D1 receptor antagonist, SCH23390 at doses which had no effect on their own. Results represent mean ± S.E.M. percent correct on the delayed alternation task. VEH = cracker vehicle; MPH = optimal dose of methylphenidate (1.0–3.0 mg/kg); SCH = SCH23390 (0.01 or 0.1 mg/kg); ** significantly different from VEH p = 0.0002; † significantly different from MPH, p = 0.008.

HHS Vulnerability Disclosure